Kappos L - Search Results

1

Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic Rims in Patients With Multiple Sclerosis.

Galbusera R, Bahn E, Weigel M, Cagol A, Lu PJ, Schaedelin SA, Franz J, Barakovic M, Rahmanzadeh R, Dechent P, Nair G, Brück W, Kuhle J, Kappos L, Stadelmann C, Granziera C. Galbusera R, et al. Among authors: kappos l. Neurology. 2024 Feb 13;102(3):e207966. doi: 10.1212/WNL.0000000000207966. Epub 2023 Dec 28. Neurology. 2024. PMID: 38165297 Free PMC article.

2

Extraocular blood flow and endothelin-1 plasma levels in patients with multiple sclerosis.

Pache M, Kaiser HJ, Akhalbedashvili N, Lienert C, Dubler B, Kappos L, Flammer J. Pache M, et al. Among authors: kappos l. Eur Neurol. 2003;49(3):164-8. doi: 10.1159/000069085. Eur Neurol. 2003. PMID: 12646761

3

Alternatives to current disease-modifying treatment in MS: what do we need and what can we expect in the future?

Kappos L, Kuhle J, Gass A, Achtnichts L, Radue EW. Kappos L, et al. J Neurol. 2004 Sep;251 Suppl 5:v57-v64. doi: 10.1007/s00415-004-1509-6. J Neurol. 2004. PMID: 15549357 Review.

4

Genomics and proteomics: role in the management of multiple sclerosis.

Kappos L, Achtnichts L, Dahlke F, Kuhle J, Naegelin Y, Sandbrink R, Lindberg RL. Kappos L, et al. J Neurol. 2005 Sep;252 Suppl 3:iii21-iii27. doi: 10.1007/s00415-005-2013-3. J Neurol. 2005. PMID: 16170496 Review.

5

Lack of association between antimyelin antibodies and progression to multiple sclerosis.

Kuhle J, Pohl C, Mehling M, Edan G, Freedman MS, Hartung HP, Polman CH, Miller DH, Montalban X, Barkhof F, Bauer L, Dahms S, Lindberg R, Kappos L, Sandbrink R. Kuhle J, et al. Among authors: kappos l. N Engl J Med. 2007 Jan 25;356(4):371-8. doi: 10.1056/NEJMoa063602. N Engl J Med. 2007. PMID: 17251533 Free article. Clinical Trial.

6

Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF.

Kuhle J, Lindberg RL, Regeniter A, Mehling M, Hoffmann F, Reindl M, Berger T, Radue EW, Leppert D, Kappos L. Kuhle J, et al. Among authors: kappos l. J Neurol. 2007 Feb;254(2):160-8. doi: 10.1007/s00415-006-0299-4. J Neurol. 2007. PMID: 17334662

7

Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients.

Lindberg RL, Achtnichts L, Hoffmann F, Kuhle J, Kappos L. Lindberg RL, et al. Among authors: kappos l. J Neuroimmunol. 2008 Feb;194(1-2):153-64. doi: 10.1016/j.jneuroim.2007.11.007. Epub 2008 Feb 21. J Neuroimmunol. 2008. PMID: 18178259

8

Non-communicating syringomyelia: a feature of spinal cord involvement in multiple sclerosis.

Weier K, Naegelin Y, Thoeni A, Hirsch JG, Kappos L, Steinbrich W, Radue EW, Gass A. Weier K, et al. Among authors: kappos l. Brain. 2008 Jul;131(Pt 7):1776-82. doi: 10.1093/brain/awn068. Epub 2008 May 31. Brain. 2008. PMID: 18515871

9

FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.

Mehling M, Brinkmann V, Antel J, Bar-Or A, Goebels N, Vedrine C, Kristofic C, Kuhle J, Lindberg RL, Kappos L. Mehling M, et al. Among authors: kappos l. Neurology. 2008 Oct 14;71(16):1261-7. doi: 10.1212/01.wnl.0000327609.57688.ea. Neurology. 2008. PMID: 18852441

10

Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.

Multiple Sclerosis Therapy Consensus Group (MSTCG); Wiendl H, Toyka KV, Rieckmann P, Gold R, Hartung HP, Hohlfeld R. Multiple Sclerosis Therapy Consensus Group (MSTCG), et al. J Neurol. 2008 Oct;255(10):1449-63. doi: 10.1007/s00415-008-0061-1. Epub 2008 Oct 29. J Neurol. 2008. PMID: 19005625

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

807 results

Search Page

Filters